Latest Ratios: P/E Ratio 5.0x · EV/EBITDA 8.1x · ROE 6.7%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $4.9B | $4.0B | $4.4B | $5.0B | $4.8B | $5.4B | $5.6B | $5.7B | $5.0B | — | — |
| Enterprise Value | $8.6B | $7.7B | $8.1B | $8.4B | $8.1B | $8.9B | $9.0B | $9.1B | $7.9B | — | — |
| P/E Ratio → | 5.02 | 5.40 | 2.50 | 3.88 | 3.44 | 6.50 | 7.11 | 5.15 | 9.53 | — | — |
| P/S Ratio | 0.37 | 0.31 | 0.35 | 0.41 | 0.41 | 0.45 | 0.43 | 0.47 | 0.43 | — | — |
| P/B Ratio | 0.33 | 0.36 | 0.41 | 0.52 | 0.55 | 0.47 | 0.52 | 0.57 | 0.58 | — | — |
| P/FCF | 8.74 | 7.20 | 3.20 | 4.67 | 3.67 | 4.19 | 11.78 | 3.56 | 3.58 | — | — |
| P/OCF | 7.06 | 5.81 | 2.94 | 4.14 | 3.41 | 3.86 | 9.43 | 3.25 | 3.25 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.59 | 0.64 | 0.68 | 0.69 | 0.75 | 0.68 | 0.76 | 0.68 | — | — |
| EV / EBITDA | 8.14 | 7.33 | 3.44 | 4.79 | 4.38 | 6.42 | 8.32 | 6.11 | 10.79 | — | — |
| EV / EBIT | 9.21 | 6.78 | 3.32 | 4.56 | 4.20 | 6.13 | 7.78 | 5.84 | 9.89 | — | — |
| EV / FCF | — | 13.94 | 5.87 | 7.84 | 6.19 | 6.94 | 18.75 | 5.73 | 5.65 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.2% | 38.2% | 37.1% | 32.8% | 33.1% | 28.0% | 23.5% | 28.5% | 22.2% | 29.0% | 28.8% |
| Operating Margin | 7.2% | 7.2% | 17.6% | 13.3% | 14.7% | 10.6% | 7.3% | 11.5% | 5.4% | 12.4% | 12.2% |
| Net Profit Margin | 5.7% | 5.7% | 13.9% | 10.4% | 11.9% | 8.3% | 6.0% | 9.2% | 4.5% | 8.8% | 8.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 6.7% | 6.7% | 17.3% | 14.0% | 14.0% | 8.8% | 7.6% | 11.8% | 5.8% | 10.7% | 10.6% |
| ROA | 1.2% | 1.2% | 2.8% | 2.1% | 2.1% | 1.4% | 1.1% | 1.7% | 0.8% | 1.5% | 1.5% |
| ROIC | 4.7% | 4.7% | 12.2% | 9.8% | 9.7% | 6.5% | 5.2% | 8.3% | 3.9% | 8.7% | 8.7% |
| ROCE | 1.5% | 1.5% | 3.6% | 2.6% | 2.7% | 1.8% | 1.4% | 2.1% | 1.0% | 2.2% | 2.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.35 | 0.35 | 0.35 | 0.37 | 0.39 | 0.31 | 0.32 | 0.35 | 0.34 | 0.31 | 0.33 |
| Debt / EBITDA | 3.69 | 3.69 | 1.63 | 2.02 | 1.84 | 2.60 | 3.28 | 2.37 | 4.07 | 1.95 | 2.07 |
| Net Debt / Equity | — | 0.34 | 0.34 | 0.35 | 0.38 | 0.31 | 0.31 | 0.35 | 0.33 | 0.30 | 0.32 |
| Net Debt / EBITDA | 3.54 | 3.54 | 1.56 | 1.94 | 1.78 | 2.54 | 3.09 | 2.31 | 3.95 | 1.90 | 2.00 |
| Debt / FCF | — | 6.74 | 2.67 | 3.17 | 2.51 | 2.75 | 6.97 | 2.17 | 2.07 | 2.74 | 2.81 |
| Interest Coverage | 5.47 | 5.47 | 12.19 | 9.42 | 10.28 | 7.81 | 6.12 | 8.79 | 4.75 | 9.78 | 9.12 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | — | — | 2.40 | 4.23 | 4.36 | 4.31 | 4.58 | 2.13 | 4.71 | 3.04 | 4.70 |
| Quick Ratio | — | — | 2.40 | 4.23 | 4.36 | 4.31 | 4.58 | 2.13 | 4.71 | 3.04 | 4.70 |
| Cash Ratio | — | — | 0.24 | 0.37 | 0.32 | 0.20 | 0.53 | 0.11 | 0.26 | 0.14 | 0.28 |
| Asset Turnover | — | 0.20 | 0.21 | 0.19 | 0.19 | 0.17 | 0.18 | 0.18 | 0.19 | 0.17 | 0.17 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 8.2% | 7.7% | 6.7% | 5.6% | 5.3% | 4.5% | 4.1% | 4.0% | 4.3% | — | — |
| Payout Ratio | 41.5% | 41.5% | 16.7% | 21.6% | 18.1% | 24.4% | 29.2% | 20.8% | 41.2% | 19.7% | 19.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 19.9% | 18.5% | 40.1% | 25.8% | 29.1% | 15.4% | 14.1% | 19.4% | 10.5% | — | — |
| FCF Yield | 11.4% | 13.9% | 31.2% | 21.4% | 27.2% | 23.9% | 8.5% | 28.1% | 27.9% | — | — |
| Buyback Yield | 20.8% | 25.3% | 21.9% | 5.0% | 4.1% | 0.9% | 0.0% | 7.1% | 7.1% | — | — |
| Total Shareholder Yield | 29.0% | 32.9% | 28.6% | 10.6% | 9.4% | 5.4% | 4.1% | 11.1% | 11.5% | — | — |
| Shares Outstanding | — | $173M | $188M | $198M | $202M | $205M | $204M | $210M | $220M | $227M | $236M |
Legacy LTC reserve volatility
As reported in recent financial data, UNMA trades at a P/B ratio of 0.33, which significantly trails peers like MetLife and Aflac, suggesting that the market continues to apply a persistent complexity discount due to the company's legacy Long-Term Care liabilities and associated earnings volatility.
The current valuation appears to reflect investor skepticism regarding the long-term runoff of the Closed Block, which often obscures the underlying profitability of the core disability business. This discount warrants further investigation into whether the market is over-penalizing the stock for legacy risks that may be nearing a natural stabilization point.
Based on quarterly filings, the combined ratio has demonstrated significant variability, ranging from a low of 72.3% in 2024Q3 to a high of 98.4% in 2025Q3, indicating that core underwriting profitability remains sensitive to unpredictable shifts in claim frequency and duration within the disability segments.
While the company maintains a generally profitable underwriting profile, the periodic spikes in the loss ratio suggest that actuarial assumptions are frequently tested by external morbidity trends. Investors should monitor whether the recent 91.0% combined ratio in 2026Q1 represents a sustainable baseline or if further volatility is likely as the company navigates post-pandemic claim patterns.
According to historical performance metrics, UNMA's ROE has fluctuated between 0.4% and 6.0% over the last ten quarters, a trend that appears heavily influenced by non-recurring reserve adjustments rather than consistent operational yield on the company's float and core underwriting margins.
The modest ROE levels suggest that the capital-intensive nature of the Closed Block continues to act as a persistent drag on overall returns. Future improvements in ROE may depend on the company's ability to successfully manage these legacy obligations while scaling its higher-margin voluntary benefits business through the Colonial Life distribution channel.
As indicated by reported financial statements, the company maintains a D/E ratio of approximately 0.35, a figure that appears unusually low for a diversified insurance carrier and suggests that standard leverage metrics may not fully capture the economic reality of the company's significant insurance-related liabilities.
This anomalous leverage profile warrants further investigation to determine if it reflects a conservative capital structure or a specific reporting carve-out that excludes hybrid capital or statutory reserve requirements. Analysts should be cautious when comparing this ratio to peers, as it may mask the true extent of the company's financial obligations.
Based on an analysis of the company's financial reporting, the P/E ratio is the most commonly misapplied metric for UNMA, as it fails to account for the significant volatility introduced by LDTI accounting and episodic reserve adjustments that do not reflect core underwriting performance.
Investors should instead prioritize after-tax operating income and adjusted book value to better gauge the company's true economic health. Relying on the P/E ratio risks misinterpreting temporary accounting noise as a fundamental shift in the company's long-term earnings power or franchise value.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying UNMA stock.
Unum Group 6.250% JR NT58's current P/E ratio is 5.0x. The historical average is 5.4x. This places it at the 38th percentile of its historical range.
Unum Group 6.250% JR NT58's current EV/EBITDA is 8.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 6.4x.
Unum Group 6.250% JR NT58's return on equity (ROE) is 6.7%. The historical average is 8.7%.
Based on historical data, Unum Group 6.250% JR NT58 is trading at a P/E of 5.0x. This is at the 38th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Unum Group 6.250% JR NT58's current dividend yield is 8.24% with a payout ratio of 41.5%.
Unum Group 6.250% JR NT58 has 38.2% gross margin and 7.2% operating margin.
Unum Group 6.250% JR NT58's Debt/EBITDA ratio is 3.7x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.